1. National Institute of Food and Drug Safety Evaluation (2020). Guideline on review and approval for digital therapeutics (for industry). Ministry of Food and Drug Safety, Cheongju, pp 3.
2. DH Park, MY Kang and HR Jeon (2023). Investment trends and future strategies for third-generation new drug digital therapeutics. Samjong KPMG, Seoul, pp 12-3. 3 (2023). Digital Therapeutics Alliance [Internet]. Available from: https://dtxalliance.org/engage/dta-members/. cited 2023 Jun 9.
3. SS Lee (2023) Strengthen international cooperation to commercialize digital health technology. Rapportian.
4. SS Lee (2019) U.S. FDA issues Breakthrough Devices Programs guideline. Medical Device Newsline.
5. BM Zegarelli (2023) FDA's digital health high notes from 2022 [Internet]. Mintz. Available from: https://www.mintz.com/insightscenter/viewpoints/2791/2023-02-06-fdasdigital-health-high-notes-2022. cited 2023 Jun 9.